Can smart monitoring catch chemo side effects early in pancreatic cancer?
NCT ID NCT04263948
First seen Nov 01, 2025 · Last updated Jun 09, 2026 · Updated 33 times
Summary
This study tested a home monitoring system for people with advanced pancreatic cancer receiving a strong chemotherapy called mFOLFIRINOX. The system tracked symptoms, weight, sleep, and activity to spot early signs of serious side effects. The goal was to see if remote monitoring could help catch problems early and reduce emergency hospital visits. 58 patients took part over 7 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREAS CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinique du Mousseau
Évry, IDF, 91000, France
Conditions
Explore the condition pages connected to this study.